CBAI - CBAID - Cord Blood America - Page 27

You didn't take your meds, did you?

LOL calm down that wasn't directed towards you.. just the question you asked.

You are clearly the one who can't handle things!

You wanna start??? Is that your intention?? I know it inst.
Dont view my comments as fighting words.. when its a discussion.

i wasnt the one who started.. let alone only stating the facts.. and ppl attack..
Lovely.

I give up. let the hype rule.

This was mentioned in a pumpers new letter to watch for tomorrow.

I don't understand why no one is talking about this... It's screaming...
Going to break .02 and up... new high...

ya its moving nicely today

Blah, Blah, Blah, Blah, Blah, Blah, Blah, I'm being realistic, Blah, Blah, Blah, Blah, Blah, This is just hype, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Blah, This is a P& D, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Look at me, Look at me, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Pay attention to me, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Blah, Blah, I'm an attention whore, Blah, Blah, Blah, Blah, Blah, Blah, Howard Stern is my Hero, Blah, Blah, Blah, Blah, Blah, Blah,

This stock is hot. Today was terrible for the market overall and CBAI held strong!! If MCET is predicted to be $1.75 in a year then this should hit over $2.00. IMO

This had a huge spike (.0198) this morning. I almost bought in at the open but waited to see how it was going to trade. Missed a few bucks there.

It's nice to see it's holding around .017 after the sell off.

CBAI cannot be stopped! The market could be down 1000 points and this thing would still be up 5%

My thoughts exactly!!


Heres a little article I found and wanted to share with you all.
http://www.parentingweekly.com/pregn...anking/faq.htm

Cord blood stem cell seems to becoming more and more popular
with patients all the time. Even my wife who is currently 7 months pregnant is interested in this.
The more I look into this stock, it should climb even if the gov. doesn't fund stem cell research. I'm an owner of this stock and I'm holding it a while. Its been holding very strong and climbing steadily almost everyday now. Even when the rest of the stocks arren't.

Its going to boom!!

CBAI is red hot! Check out a new blog call http://tradingstemcells2009.blogspot.com It provides information and tracks the trends of many of the stem cell stocks. CBAI is featured quite a bit. Today it has an interesting article about when might be a good time to close your positions in the stem cell names. It's not a "basher" article, but just food for thought.

Thanks lynn... always nice to have news passed to me...

I like this part of the article the best....
Not even the red hot Stem Cell stocks were immune from today's rough stock market. It's easy to get lulled into thinking that a stock in a hot sector will continue to rise day after day, but it's days like today that bring stock traders or investors back down to reality.


Its true... its really not going to go up day after day. It reminds me of some of the people that post on here (mad) because they bought this stock and it didn't go up in the 45 minutes they owned it. It will have days like today but its rises will beat its falls, creating a gradual increase. You can see this in the chart I posted above.

Cord Blood Announces $1 Million Reduction in Long Term Debt

Feb 12, 2009 06:00:00 (ET)


SANTA MONICA, Calif., Feb 12, 2009 /PRNewswire-FirstCall via COMTEX/ -- Cord Blood America, Inc. (CBAI, Trade ), the umbilical cord blood stem cell preservation company ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, is pleased to announce that between January 1, 2009, and today, it has reduced its long term debt by approximately $1 million.

The Company previously said in press releases and CEO interviews that a major focus is to reduce debt and strengthen the Cord Blood America balance sheet. The mentioned debt was either converted into equity of reduced by principal cash payment. Cord Blood America said the effort to further reduce debt will continue throughout 2009.

CEO Matthew Schissler commented: "It's a start. De-levering our balance sheet coupled with strategic growth and acquisitions are the primary goals for 2009. I'm certain shareholders would agree that removing debts will help put the company in a strong position for long term growth in the stem cell industry."

About Cord Blood America

Cord Blood America (CBAI, Trade ) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (CBAI, Trade ), visit our website at www.corcell.com . For investor information, visit www.cordblood-america.com .


CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com

Very positive news ...They really dont have that much debt, and fore casted revenues look great.

I am still awaiting Obama to shift focus from this stupid stimulus bill to Medical Care / Stem cells.

IMO this stock has no where to go but up (once that happens). The flippers really aren't attacking this as far as i can tell. Volume has decreased but allot of people holding.

I dont know is its been discussed but CBAI is listed on the ETF Innovators Stem Cell Index. There are allot of Big Board stocks in that index (such as GERN)

I am definitely long on this one, i got in at .0030 - already up about 350% on my original investment . The MM's are just shorting this thing like crazy ... kinda looks like GNTA. Good luck to all

Cord Blood America Now Part of New ETF Innovators Stem Cell Index

updated 9:35 a.m. ET, Mon., Feb. 9, 2009
SANTA MONICA, CA - Cord Blood America, Inc. (OTCBB: CBAI), the umbilical cord bloodstem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that the Company is now listed on the ETF Innovators Emerging Stem Cell Index of U.S.-listed stocks. For more information, see the social media news room at http://www.intelligendo.com.

ETF Innovators, known for creating new global equity indexes with a focus in the healthcare industry, will track the total market value and stock price changes as an indicator of investor and trader sentiment toward the stem cell and regenerative medicine space.

"We are pleased by this recognition. Two thousand and nine has been, so far, both very interesting and positive for stem cell companies, and we're pleased to see this impressive index following our sector," said Matthew Schissler, Founder and CEO of Cord Blood America.

More info on the index :

Shares of Geron (GERN) and other well known stem cell and regenerative medicine stocks such as Osiris Therapeutics (OSIR) and StemCells (STEM) have been soaring since the FDA allowed human clinical testing for Geron's embryonic stem cell treatment candidate for spinal cord injuries.

The accompanying table (click to enlarge) highlights 25 U.S.-listed stem cell and regenerative medicine companies with market caps of below $200M which are included in the ETF Innovators Emerging Stem Cell Index. The companies are also listed below in descending order by market cap.

BioMimetic Therapeutics (BMTI)
Cytori Therapeutics (CYTX)
RTI Biologics (RTIX)
Aastrom Biosciences (ASTM)
Mesoblast (MBLTY)
Neuralstem (CUR)
Osteotech (OSTE)
ThermoGenesis (KOOL)
RegeneRx Biopharma (RGN)
Advanced Cell Tecchology (ACTC)
Pluristem Therapeutics (PSTI)
Athersys (ATHX)
International Stem Cell Corp (ISCO)
Stem Cell Innovations (SCLL)
Bioheart (BHRT)
CellCyte Genetics Corp (CCYG)
Stem Cell Therapeutics (SCTPF)
Brainstorm Cell Therapeutics (BCLI)
Opexa Therapeutics (OPXA)
Stem Cell Authority (SCAL)
Neostem (NBS)
Stem Cell Therapy Internt'l (SCII)
Cord Blood America (CBAI)
MultiCell Technologies (MCET)
LifeStem International (LSTM)

While regenerative medicine holds enormous potential for breakthrough medical treatments, investors and traders should be cautious as the entire space is an extreme momentum trade since the FDA news to allow human testing of embryonic stem cells. President Obama is also expected to lift the federal ban under the previous administration to allow federal funding of stem cell research, providing another boom to these companies.